ArticleJournal of health economics and outcomes research2024

Real-World HbA1c Changes Among Type 2 Diabetes Mellitus Patients Initiating Treatment With a 1.0 Mg Weekly Dose of Semaglutide for Diabetes.

Noelle N Gronroos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.